HealthEquity Q1 Beats on Revenue, Raises FY27 Outlook Amid Flywheel Momentum

Revenue and profitability HealthEquity reported $354.6 million in total revenue for the quarter, a 7% increase over the same period last year. The boost came from all three core lines – service revenue ($122.9 million), custodial revenue ($174.3 million) and interchange revenue ($57.4 million). Adjusted EBITDA rose to $163 million, translating into a margin of 46%, up from 42% a year ago, underscoring the firm’s ability to convert top‑line growth into cash flow as scale improves.

* Guidance upgrade Management lifted its fiscal‑2027 outlook, projecting revenue of $1.410 billion to $1.420 billion, up roughly 4% from prior guidance. Net income is now expected between $242 million and $248 million, or $2.88‑$2.95 per diluted share, while non‑GAAP net income is forecast at $392 million‑$398 million ($4.66‑$4.73 per share) based on 84 million weighted‑average shares. Adjusted EBITDA is slated for $625 million‑$633 million, reinforcing the firm’s focus on cash generation.

Segment dynamics - Service revenue grew modestly but contributed the highest margin of the three streams, reflecting higher fee income from account administration and member services. At $122.9 million it represents roughly 35% of total revenue. - Custodial revenue* surged to $174.3 million, driven by a $1.0 billion balance of client‑held funds. The custodial model is low‑cost and benefits directly from the expanding HSA asset base. - Interchange revenue added $57.4 million, a line that scales with transaction volume on HealthEquity’s debit cards and shows resilience despite broader payment‑industry volatility.

Overall, custodial revenue now accounts for about 49% of total sales, highlighting the importance of the firm’s cash‑management platform as assets grow.

* Operational metrics – the flywheel in action HealthEquity’s core operating engine is its expanding HSA ecosystem. The company reported 10.6 million HSAs, an 8% YoY increase, and 909,000 HSAs with investments, up 18% year over year. Total HSA assets swelled to $37.1 billion, a 19% jump, split almost evenly between cash ($17.5 bn) and investment assets ($19.6 bn). The growth in invested balances improves fee upside because investment‑related fees are higher than cash‑only fees.

Total accounts rose to 17.8 million, bolstered by 7.2 million complementary consumer‑direct benefits (CDBs), which broaden the addressable market and create cross‑sell opportunities for HSA products. The breadth of the platform reduces reliance on new account acquisition; as existing accounts mature they generate higher fee revenue, a point management emphasized when describing the “flywheel” effect.

* Capital allocation – share repurchases and cash discipline The company repurchased 1.5 million shares for $123 million in Q1, reflecting strong free‑cash flow generation. Moreover, HealthEquity added a $1 billion authorization to its existing buyback program, signaling confidence that the business can sustain high levels of cash return to shareholders while still funding growth initiatives.

* Margin expansion and operating leverage Adjusted EBITDA margin widened from 42% to 46%, driven by two forces: (1) a higher proportion of low‑cost custodial revenue within the mix, and (2) continued technology efficiencies that keep incremental costs modest as volumes rise. Fixed cost absorption improves with each new account or asset dollar, delivering a classic scale advantage.

* Risk considerations Management’s forward‑looking statements flagged several headwinds: custodial asset safety, competitive pressure from other HSA providers, potential regulatory changes affecting tax‑advantaged benefits, and cybersecurity risks inherent to a digital health‑finance platform. While none of these have materialized into immediate financial impact, they remain key variables for investors monitoring the space.

* Market reaction HealthEquity’s stock jumped 4.6% in after‑hours trading, outpacing the S&P 500’s 0.57% gain on the day. The rally reflects investor enthusiasm for both the earnings beat and the upgraded outlook, as well as the sizable buyback authorization which adds a near‑term catalyst.

* Comparative perspective Against peers such as Fidelity’s HSA platform and Paychex’s benefits business, HealthEquity’s growth rates in accounts (8% YoY) and assets (19% YoY) rank at the higher end of the market. The firm’s focus on a pure‑play HSA custodian model gives it a differentiated cost structure that is beginning to translate into superior margin expansion.

* Outlook Management’s guidance suggests a continuation of the current trajectory, with revenue expected to breach the $1.4 billion mark and Adjusted EBITDA staying above $600 million. The firm’s ability to sustain HSA account growth while deepening investment balances will be critical; any slowdown could compress fee yields. Conversely, successful cross‑selling of complementary CDBs and further digitization of member experiences could accelerate the flywheel.

* Bottom line HealthEquity delivered a robust first quarter that not only beat expectations but also set a higher bar for fiscal 2027. The combination of strong top‑line growth, expanding margins, disciplined capital returns and an upgraded outlook positions the company as a compelling play in the rapidly evolving consumer‑direct health‑benefits arena.